Clinical trial
Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In…
NCT00419237 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00419237 |
|---|---|
| Title | Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function |
| Official title | A Study to Investigate the Pharmacokinetics of a Single Inhaled Dose (400mcg) of GW685698X and Its Effect on Serum Cortisol in Patients With Impaired Liver Function and Matched Control Subjects. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | GW685698X |
| Enrollment | 20 |
| Start date | Jan 13, 2005 |
| Primary completion | Apr 15, 2005 |
| Completion | Apr 15, 2005 |
| First posted | Jan 8, 2007 |
| Last update posted | Nov 6, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: